On the stock market since 2018, it operates in the world of health and science. It has 366 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 105% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $404.6M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Executive Buying: The trades send no strong signal of confidence.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 3 years, sales grew about 45% a year on average.
There is $414.1M in the vault; even if every debt were paid off, $404.6M would remain.
The company’s market value is 99 times its annual profit. Even a small disappointment could hit the price hard.
The price action doesn’t yet back an upward turn. Council score: 0/10.
No clear buy-side message is coming from the executive floor. Council score: 3/10.
On our five-subject report card, KNSA sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: KNSA is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.